Transcription of Overview ICH GCP E6(R2) Integrated Addendum
{{id}} {{{paragraph}}}
Example: marketing
Overview ICH GCP E6(R2) Integrated Addendum
OverviewICH GCP E6(R2) 2017 Biomedical Research Alliance of New York LLCCITI Program is a division of BRANYI ntroductionOn 15 December 2016, the International Council for Harmonistion (ICH) adopted the revised E6 guideline, entitled Integrated Addendum to Good Clinical Practice (GCP). Now, regulatory implementation is carried out according to the same national/regional procedures that apply to other regulatory guidelines and requirements (ICH 2017). does the new guidelineaffect?The ICH E6 Addendum affects the full clinical trial cycle and research enterprise. The revisions to the guideline mainly affect sponsors, stipulating a more proactive approach to study design, as well as risk management and study monitoring. However, Contract Research Organizations (CROs), that often delegated trial-related tasks by the sponsor,need to learn about the revised practice points in the guideline.
The European Medicine Agency (EMA) submitted a report in 2014 summarizing 398 GCP inspections of clinical trial sponsors, sites, and CROs from 2000-2012. The report’s critical and major findings were mostly in relation ... The revised guideline uses an addendum-integrated format. This format embeds the revisions into ...
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: